Back
Plus Therapeutics, Inc. Stock Price Chart
Stock Forecasting AI Could Help Triple Your Money This Year
Try it now for free.
Sell
37
PSTV
Plus Therapeutics, Inc.
Last Price:
$0.55
Seasonality Move:
6.73%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
Plus Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.58 | Buy |
| 20-day SMA: | 0.62 | Sell |
| 50-day SMA: | 0.58 | Buy |
| 200-day SMA: | 0.57 | Buy |
| 8-day EMA: | 0.59 | Sell |
| 20-day EMA: | 0.6 | Sell |
| 50-day EMA: | 0.59 | Sell |
| 200-day EMA: | 0.68 | Sell |
Plus Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 47.96 | Sell |
| Chaikin Money Flow: | 1945620 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.55 - 0.65) | Sell |
| Bollinger Bands (100): | (0.48 - 0.68) | Sell |
Plus Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Plus Therapeutics, Inc. Stock
Is Plus Therapeutics, Inc. Stock a Buy?
-
Plus Therapeutics, Inc. share price is 0.58 while PSTV 8-day simple moving average is 0.58, which is a Buy signal.
-
The stock price of PSTV is 0.58 while Plus Therapeutics, Inc. 20-day SMA is 0.62, which makes it a Sell.
-
Plus Therapeutics, Inc. 50-day simple moving average is 0.58 while PSTV share price is 0.58, making it a Buy technically.
-
PSTV stock price is 0.58 and Plus Therapeutics, Inc. 200-day simple moving average is 0.57, creating a Buy signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
37
Plus Therapeutics, Inc. (PSTV)
is a Sell
Is Plus Therapeutics, Inc. a Buy or a Sell?
-
Plus Therapeutics, Inc. stock is rated a SellThe current Plus Therapeutics, Inc. [PSTV] share price is $0.58. The Score for PSTV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics, Inc. Stock Info
Market Cap:
79.7M
Price in USD:
0.58
Share Volume:
1.9M
Plus Therapeutics, Inc. 52-Week Range
52-Week High:
2.31
52-Week Low:
0.16
Sell
37
Plus Therapeutics, Inc. (PSTV)
is a Sell
Plus Therapeutics, Inc. Share Price Forecast
-
What is the Plus Therapeutics, Inc. stock price today?The Plus Therapeutics, Inc. stock price is 0.58 USD today.
-
Will PSTV stock go up or go down?Plus Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Plus Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics, Inc. is overvalued.
Is Plus Therapeutics, Inc. Stock a Buy?
-
Plus Therapeutics, Inc. share price is 0.58 while PSTV 8-day exponential moving average is 0.59, which is a Sell signal.
-
The stock price of PSTV is 0.58 while Plus Therapeutics, Inc. 20-day EMA is 0.60, which makes it a Sell.
-
Plus Therapeutics, Inc. 50-day exponential moving average is 0.59 while PSTV share price is 0.58, making it a Sell technically.
-
PSTV stock price is 0.58 and Plus Therapeutics, Inc. 200-day simple moving average is 0.68, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics, Inc.
Is Plus Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.84 per share, and an increase next year of $0.09 per share.
Technical Analysis of Plus Therapeutics, Inc.
Should I short Plus Therapeutics, Inc. stock?
-
PSTV Moving Average Covergence Divergence (MACD) indicator is -0, suggesting Plus Therapeutics, Inc. is a Sell
-
Plus Therapeutics, Inc. Relative Strength Index (RSI) is 47.96, which suggest Plus Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Plus Therapeutics, Inc. is (0.55 - 0.65), which suggest Plus Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Plus Therapeutics, Inc. is (0.48 - 0.68), which suggest Plus Therapeutics, Inc. is a Sell
* Plus Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.